Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exubera vs Lantus in Type 2 Diabetes Mellitus
NCT00391027Phase 4Completed
- Sponsor
- Pfizer
- Start
- Dec 2006
- Primary completion
- Aug 2008
- Countries
- 10
01
Overview
Phase 4, randomised, open-label trial of insulin human in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Pfizer. Primary endpoint: Change From Baseline in Glycosylated Hemoglobin at 26 weeks. Started Dec 2006; status: completed.
02
Drugs
insulin human
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00391027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00391027.